Jacque Sokolov, MD named as one of the Directorship 100 by NACD

Jacque Sokolov, MD, CEO of SSB Solutions, was named as one of the Directorship 100 at an award ceremony in New York City on June 22, 2022.  The Directorship 100 is a recognition of the most influential people in the boardroom and corporate governance community and is bestowed by the National Association of Corporate Directors (NACD)

The 2022 D100 comprises 50 directors and 50 governance professionals and institutions who exemplify the knowledge, leadership, and excellence NACD promotes. Awardees play a significant role in shaping the greater boardroom agenda.

 Continue reading

Arizona Algae and Nooter/Eriksen Announce Partnership in Development and Commercialization of Extracted and Refined Algae Products

St. Louis, MO and Holbrook, AZ, July 11, 2022 — Arizona Algae Products, LLC, a leading algae producer and innovative biotechnology company and Nooter/Eriksen, Inc., a global leader in sustainable energy, today announced that the companies have entered into a strategic partnership for the development and commercialization of extracted and refined algae products, with an initial focus on algal EPA omega-3 oils. The partnership leverages the companies’ complementary skill sets in advancing the methods and production capabilities for a variety of algae products.Continue reading

First in Human Subjects Enrolled in Aqualung Therapeutics Phase 1A Study Evaluating Safety, Tolerability and Pharmacokinetics of ALT-100

TUCSON, AZ / ACCESSWIRE / July 5, 2022 / Aqualung Therapeutics, an early stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced today that their first two patients have been enrolled in the phase 1A healthy human volunteer Study. The data from this study will be used to understand and validate dosing and safety of the humanized monoclonal antibody therapeutic ALT-100 for future clinical trials that address diseases driven by unchecked inflammation.Continue reading